TrialThe New England journal of medicine2015
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
Jan A Burger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
796 papers cite itlatest 60 shown
this paperpooled ittrialcites it